Serum levels of nesfatin-1 and irisin in obese children

Eda Dokumacioglu1, Hatice Iskender1, Arzu Sahin2

  • 1Department of Nutrition and Dietetics, Faculty of Healthy Sciences, Artvin Çoruh University, Artvin, Turkey.

Insights

Childhood obesity is linked to lower nesfatin-1 and SOD levels, but higher irisin and MDA levels. Understanding these biomarkers may aid in developing new obesity treatments.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Biochemistry

Background:

  • Decreased physical activity and increased technology use contribute to rising childhood obesity rates.
  • Childhood obesity remains a significant global health concern despite awareness and interventions.

Purpose of the Study:

  • To investigate serum levels of nesfatin-1 and irisin in obese children.
  • To explore the relationship between obesity and specific biomarkers.

Main Methods:

  • A case-control study involving 32 obese children and 30 healthy children.
  • Measurement of serum nesfatin-1, irisin, SOD, MDA, and various metabolic/inflammatory markers.

Main Results:

  • Obese children exhibited lower mean serum nesfatin-1 and SOD levels compared to controls (p <0.05, p <0.001).
  • Obese children showed higher mean serum irisin and MDA levels than controls (p <0.001).

Conclusions:

  • Nesfatin-1 and irisin may play a role in the pathophysiology of childhood obesity.
  • Further research on the obesity-irisin-nesfatin-1 triad could inform future obesity treatment strategies.